HK Pharmacist Registration flashcards
HK Pharmacist Registration · Build recall with a focused review session.
31 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Pharmacy and Poisons Board
- Statutory body under Cap. 138 that registers pharmacists, issues practising certificates, and inquires into professional misconduct or fitness to practise; its disciplinary decisions are subject to appeal.
- First Schedule poisons
- Category of poisons under Cap. 138 subject to the strictest controls: sale only by or under a registered pharmacist, full record-keeping, prescribed labelling and secure storage requirements.
- Second Schedule poisons
- Poisons listed in the Second Schedule of Cap. 138, subject to controls less stringent than First Schedule poisons but still restricted to sale by registered pharmacists or licensed sellers.
- Third Schedule exemptions
- Provisions of Cap. 138 that do not apply to substances listed in the Third Schedule, such as certain diluted preparations or specified uses; classification must be checked before sale.
- Fourth Schedule antibiotics
- Antibiotics listed in the Fourth Schedule of Cap. 138, which may be supplied only on a prescription from a registered medical practitioner, dentist or veterinary surgeon.
- Poison register entries
- Required record for First Schedule poisons: date of sale, name and quantity of poison, purchaser's name and address, and prescriber details, retained for the prescribed period and open to inspection.
- POISON label requirement
- Containers of poisons must bear the word POISON, or its Chinese equivalent, in the prescribed form, together with the poison name, quantity, seller details and any required caution.
- Pharmacist registration requirements
- To register under Cap. 138 a person needs an approved pharmacy degree, supervised practical training, and success in the Board's registration examination, followed by annual practising certificate renewal.
- Professional misconduct inquiry
- Board proceeding under Cap. 138 that may be triggered by misconduct, a dishonesty conviction or unfitness to practise, with outcomes including removal from the register or suspension.
- Pharmacy and Poisons Regulations
- Subsidiary legislation under Cap. 138 setting detailed rules on record-keeping, labelling, containers, storage and inspection of poisons and pharmacy premises.
- Unregistered person sale offence
- Selling a First Schedule poison without being a registered pharmacist, or outside pharmacist supervision, is an offence under Cap. 138 unless a specific statutory exemption applies.
- Chinese Medicine Ordinance separation
- Cap. 549 governs Chinese medicine practitioners and medicines separately from Cap. 138; registration under one regime does not authorise practice or dispensing under the other.
- Prescription validity check
- Before dispensing, confirm prescriber legitimacy, patient identity, drug, strength, dose, frequency, duration and route; incomplete or ambiguous prescriptions must be clarified with the prescriber.
- Repeat dispensing limits
- Repeats may be supplied only where authorised, within the stated interval and maximum number; exceeding the authorised repeats or interval is a dispensing and record-keeping breach.
- Patient counselling elements
- Counselling should cover indication, dose, administration, common and serious adverse effects, interactions, storage and missed-dose advice, with confirmation that the patient understands.
- Generic substitution rule
- Substitution is permitted only where legally allowed and clinically appropriate, considering bioequivalence, formulation and patient factors, and never where the prescriber has prohibited substitution.
- High-risk medicine double-check
- Calculations for high-risk medicines and extemporaneous preparations should be independently double-checked, with batch and expiry recorded, to reduce dosing and compounding errors.
- Controlled drug secure storage
- Controlled and high-risk medicines must be stored under lock with restricted access, and stock movements recorded, to prevent diversion and comply with statutory storage requirements.
- Patient confidentiality limits
- Patient information may be disclosed only with consent or where required by law, such as statutory notification, a court order or a serious public health risk.
- Dispensing error disclosure
- Errors must be documented, disclosed to the patient where harm is possible, reported through the incident system and reviewed to prevent recurrence; concealment is professional misconduct.
- Advertising professional services
- Advertising must not be false, misleading or create unjustified expectations, and inducements must not compromise the pharmacist's independent professional judgement.
- Continuing professional development
- Maintaining and demonstrating competence through ongoing CPD is a professional duty; practising outside one's competence without referral or supervision raises a conduct issue.
- Extemporaneous preparation record
- Records for compounded preparations should include formula, ingredients, batch numbers, expiry date, preparer and checker, enabling traceability and recall if a problem arises.
- Prescription retention duty
- Dispensed prescriptions must be retained and recorded as required by the regulations, and made available for inspection by authorised officers on request.
- Supervision of pharmacy sale
- Sale of First Schedule poisons in a pharmacy must occur under the supervision of a registered pharmacist who is present and able to exercise professional control.
- Practising certificate renewal
- Annual renewal of the practising certificate is required to practise as a pharmacist; practising without a valid certificate is an offence and a professional conduct issue.
- Inspection powers
- Authorised officers may enter and inspect pharmacy premises, examine stocks and records of poisons, and require production of documents to verify compliance with Cap. 138.
- Therapeutic substitution caution
- Switching to a different drug or formulation requires prescriber agreement unless expressly authorised; the pharmacist must assess clinical suitability and document the change.
- Medication error reporting culture
- A non-punitive reporting culture encourages prompt reporting of near misses and errors, supports system fixes, and is distinct from the duty to disclose harm to patients.
- Conflict of interest duty
- Pharmacists must declare and manage financial or personal interests that could influence recommendations, and must place patient welfare above commercial gain.
- Referral when outside competence
- When a patient's needs exceed the pharmacist's competence or scope, the pharmacist must refer appropriately rather than proceed unsupervised.